Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus [version 2; referees: 2 approved]

Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple different organs, including the kidneys and central nervous system (CNS). Conventional radiological examinations in SLE patients include volumetric/ anatomical computed tomography (CT), magnetic resonance imaging (M...

Full description

Bibliographic Details
Main Authors: Joshua M. Thurman, Natalie J. Serkova
Format: Article
Language:English
Published: F1000 Research Ltd 2015-10-01
Series:F1000Research
Subjects:
Online Access:http://f1000research.com/articles/4-153/v2
_version_ 1818277060967137280
author Joshua M. Thurman
Natalie J. Serkova
author_facet Joshua M. Thurman
Natalie J. Serkova
author_sort Joshua M. Thurman
collection DOAJ
description Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple different organs, including the kidneys and central nervous system (CNS). Conventional radiological examinations in SLE patients include volumetric/ anatomical computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound (US). The utility of these modalities is limited, however, due to the complexity of the disease. Furthermore, standard CT and MRI contrast agents are contraindicated in patients with renal impairment. Various radiologic methods are currently being developed to improve disease characterization in patients with SLE beyond simple anatomical endpoints. Physiological non-contrast MRI protocols have been developed to assess tissue oxygenation, glomerular filtration, renal perfusion, interstitial diffusion, and inflammation-driven fibrosis in lupus nephritis (LN) patients. For neurological symptoms, vessel size imaging (VSI, an MRI approach utilizing T2-relaxing iron oxide nanoparticles) has shown promise as a diagnostic tool. Molecular imaging probes (mostly for MRI and nuclear medicine imaging) have also been developed for diagnosing SLE with high sensitivity, and for monitoring disease activity. This paper reviews the challenges in evaluating disease activity in patients with LN and neuropsychiatric systemic lupus erythematosus (NPSLE). We describe novel MRI and positron-emission tomography (PET) molecular imaging protocols using targeted iron oxide nanoparticles and radioactive ligands, respectively, for detection of SLE-associated inflammation.
first_indexed 2024-12-12T22:55:33Z
format Article
id doaj.art-675109698b5746dc9c6f46944c0ddae4
institution Directory Open Access Journal
issn 2046-1402
language English
last_indexed 2024-12-12T22:55:33Z
publishDate 2015-10-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj.art-675109698b5746dc9c6f46944c0ddae42022-12-22T00:08:57ZengF1000 Research LtdF1000Research2046-14022015-10-01410.12688/f1000research.6587.27839Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus [version 2; referees: 2 approved]Joshua M. Thurman0Natalie J. Serkova1Department of Medicine, University of Colorado School of Medicine, Aurora, CO, 80045, USADepartment of Anesthesiology, University of Colorado School of Medicine, Aurora, CO, 80045, USASystemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple different organs, including the kidneys and central nervous system (CNS). Conventional radiological examinations in SLE patients include volumetric/ anatomical computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound (US). The utility of these modalities is limited, however, due to the complexity of the disease. Furthermore, standard CT and MRI contrast agents are contraindicated in patients with renal impairment. Various radiologic methods are currently being developed to improve disease characterization in patients with SLE beyond simple anatomical endpoints. Physiological non-contrast MRI protocols have been developed to assess tissue oxygenation, glomerular filtration, renal perfusion, interstitial diffusion, and inflammation-driven fibrosis in lupus nephritis (LN) patients. For neurological symptoms, vessel size imaging (VSI, an MRI approach utilizing T2-relaxing iron oxide nanoparticles) has shown promise as a diagnostic tool. Molecular imaging probes (mostly for MRI and nuclear medicine imaging) have also been developed for diagnosing SLE with high sensitivity, and for monitoring disease activity. This paper reviews the challenges in evaluating disease activity in patients with LN and neuropsychiatric systemic lupus erythematosus (NPSLE). We describe novel MRI and positron-emission tomography (PET) molecular imaging protocols using targeted iron oxide nanoparticles and radioactive ligands, respectively, for detection of SLE-associated inflammation.http://f1000research.com/articles/4-153/v2AutoimmunityLiver Biology & Pathobiology
spellingShingle Joshua M. Thurman
Natalie J. Serkova
Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus [version 2; referees: 2 approved]
F1000Research
Autoimmunity
Liver Biology & Pathobiology
title Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus [version 2; referees: 2 approved]
title_full Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus [version 2; referees: 2 approved]
title_fullStr Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus [version 2; referees: 2 approved]
title_full_unstemmed Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus [version 2; referees: 2 approved]
title_short Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus [version 2; referees: 2 approved]
title_sort non invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus version 2 referees 2 approved
topic Autoimmunity
Liver Biology & Pathobiology
url http://f1000research.com/articles/4-153/v2
work_keys_str_mv AT joshuamthurman noninvasiveimagingtomonitorlupusnephritisandneuropsychiatricsystemiclupuserythematosusversion2referees2approved
AT nataliejserkova noninvasiveimagingtomonitorlupusnephritisandneuropsychiatricsystemiclupuserythematosusversion2referees2approved